Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Terbutaline modified-release - Vectura

Next Previous
Drug Profile

Terbutaline modified-release - Vectura

Alternative Names: SKP-1052

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SkyePharma PLC
  • Developer Vectura
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Small molecules; Tocolytics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Hypoglycaemia

Highest Development Phases

  • No development reported Hypoglycaemia

Most Recent Events

  • 28 Sep 2018 No recent reports of development identified for phase-I development in Hypoglycaemia(Prevention) in Germany (PO, Tablet)
  • 08 Sep 2016 Terbutaline modified-release is still in phase I development for Hypoglycaemia (Prevention) (Skyepharma Pipeline, September 2016)
  • 02 Sep 2011 Terbutaline modified-release - Skye Pharma is available for licensing as of 02 Sep 2011.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top